Standard Biotools (LAB) Gross Profit (2010 - 2026)

Standard Biotools (LAB) has 17 years of Gross Profit data on file, last reported at $11.3 million in Q1 2026.

• Gross Profit for Q1 2026 came in at $11.3 million, up 2.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $42.8 million (down 4.69% YoY), and the FY2025 annual result was $42.5 million, down 5.21% from the prior year.
• Gross Profit declined to $11.3 million in Q1 2026 per LAB's latest filing, from $11.4 million in the prior quarter.
• Over five years, Gross Profit peaked at $24.6 million in Q1 2022 and troughed at $4.4 million in Q2 2022.
• A 5-year average of $12.5 million and a median of $11.3 million in 2026 frame the typical range for Gross Profit.
• The sharpest annual moves came in 2022 and 2023: Gross Profit plunged 75.79% in 2022, then surged 207.25% in 2023.
• A 5-year view of Gross Profit shows it stood at $11.2 million in 2022, then rose by 19.61% to $13.4 million in 2023, then dropped by 14.97% to $11.4 million in 2024, then climbed by 0.22% to $11.4 million in 2025, then dropped by 0.65% to $11.3 million in 2026.
• Business Quant data shows LAB's Gross Profit at $11.3 million in Q1 2026, $11.4 million in Q4 2025, and $9.5 million in Q3 2025.